Segall Bryant & Hamill’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Segall Bryant & Hamill’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-48,703	Closed	-$2.29M	–	744
2022 Q3	$2.29M	Sell	48,703 -28,152	-37%	-$1.82M	0.03%	413
2022 Q2	$5.51M	Buy	76,855 +7,946	+12%	+$581K	0.06%	293
2022 Q1	$5.58M	Sell	68,909 -12,500	-15%	-$1.06M	0.05%	312
2021 Q4	$8.36M	Buy	81,409 +2,336	+3%	+$224K	0.08%	230
2021 Q3	$6.92M	Buy	79,073 +465	+0.6%	+$42.1K	0.07%	270
2021 Q2	$7.03M	Buy	78,608 +48,650	+162%	+$4.11M	0.07%	264
2021 Q1	$2.27M	Sell	29,958 -8,301	-22%	-$626K	0.02%	458
2020 Q4	$2.61M	Buy	+38,259	New	+$2.39M	0.03%	387

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Segall Bryant & Hamill's SYNH Position: Q4 2022 in Review

Segall Bryant & Hamill sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 48,703 shares — an estimated $2.29M sold.

Segall Bryant & Hamill first reported a position in SYNH in Q4 2020 and held it in 8 quarters. The position peaked at $8.36M in Q4 2021. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

Segall Bryant & Hamill reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Segall Bryant & Hamill sold 48,703 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $2.29M.
Segall Bryant & Hamill first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2020 and held it in 8 quarters.
Segall Bryant & Hamill's Syneos Health, Inc. Class A Common Stock position peaked at $8.36M in Q4 2021.
307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Segall Bryant & Hamill's 13F filing for Q4 2022, filed 14 Feb 2023.